期刊文献+

宫颈癌患者术后盆底功能障碍性疾病的相关因素分析 被引量:8

Study on the related factors of pelvic floor dysfunction in patients with cervical cancer after surgery
下载PDF
导出
摘要 目的探讨宫颈癌患者术后发生盆底功能障碍性疾病的相关因素,为预防和临床治疗提供一定的参考依据。方法收集121例宫颈癌患者的临床资料,采用Logistic逐步回归分析法对宫颈癌患者术后发生盆底功能障碍性疾病的危险因素进行分析。结果 121例宫颈癌患者中,74例(61.16%)患者术后发生了盆底功能障碍性疾病。单因素分析发现,年龄、肿瘤直径、绝经情况和留置尿管时间对盆底功能障碍性疾病的发生有影响。多因素分析发现,年龄≥45岁(OR=2.380,95%CI:1.194~4.744)、肿瘤直径≥4 cm(OR=1.866,95%CI:1.870~2.935)、绝经(OR=1.902,95%CI:1.217~2.974)和留置尿管时间≥7 d(OR=4.010,95%CI:1.259~12.773)是宫颈癌患者术后发生盆底功能障碍性疾病的独立危险因素。结论宫颈癌根治术后盆底功能障碍性疾病的发生率较高,对于年龄较大、绝经、分娩次数较多的患者应尽早采取相应措施,减少盆底功能障碍性疾病的发生率。 Objective To investigate the factors associated with postoperative pelvic floor dysfunction in patients with cervical cancer and to provide some scientific references for prevention and clinical treatment. Method A total of121 patients with cervical cancer were enrolled in this study. Logistic stepwise regression was used to analyze the factors influencing the pelvic floor dysfunction in these patients. Result In the cohort of 121 cases of cervical cancer, 74(61.16%) patients had pelvic floor dysfunction. The univariate analysis found that age, tumor diameter, menopause and time of indwelling catheter(days) were associated with the occurrence of pelvic floor dysfunction disorders. In multivariate analysis, age≥45(OR=2.380, 95%CI: 1.194-4.744), tumor diameter ≥ 4 cm(OR=1.866, 95%CI: 1.870-2.935), menopause(OR=1.902, 95%CI: 1.217-2.974) and time of indwelling catheter≥7 days(OR=4.010, 95%CI: 1.259-12.773) were independent risk factors of pelvic floor dysfunction. Conclusion The incidence of pelvic floor dysfunction after radical hysterectomy is high, and older, postmenopausal patients with more times of gravidity and parity should be monitored in advance to reduce the incidence of pelvic floor dysfunction.
作者 向楠 陈涛
出处 《癌症进展》 2017年第10期1200-1202,共3页 Oncology Progress
关键词 宫颈癌 盆底功能障碍性疾病 影响因素 cervical cancer pelvic floor dysfunction influence factors
  • 相关文献

参考文献7

二级参考文献36

  • 1全国肿瘤登记中心.中国肿瘤登记工作指导手册[M].北京:中国协和医科大学出版社,2004.48-50.
  • 2Ferlay J,Shin HR,Bray F,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Can- cer,2010,127(12):2893-2917.
  • 3Curado MPEB,Shin HR,Storm H,et al. Cancer incidence in Five Continents,Vol. IX[M]. Lyon: IARC Scientific Pub- lications, 2008.
  • 4Bray F,Parkin DM. Evaluation of data quality in the cancer registry: Principles and methods. Part 1: Comparability,va- lidity and timeliness[J]. Eur J Cancer, 2009,45(5): 747-755.
  • 5Felay J,Burkhard C,Whelan S,et al. Check and Conver- sion Programs for Cancer Registries.(IARC/IACR tools for Cancer Registries) IARC Technical Report No.42 [M]. Ly- on: IARC,2005.
  • 6Haggar FA,Preen DB,Pereira G,et al. Cancer incidence and mortality trends in Australian adolescents and young adults, 1982-2007[J]. BMC Cancer, 2012,12:151.
  • 7Dickinson JA,Stankiewicz S,Popadiuk C,et al. Reduced cer- vical cancer incidence and mortality in Canada: national data from 1932 to 2006{J]. BMC Public Health ,2012,12: 992.
  • 8Matsukura T,Sugase M. Pitfalls in the epidemiologic clas- sification of human papillomavirus types associated with cervical cancer using polymerase chain reaction:driver and passenge[J].Int J Gynecol Cancer,2008, 18(5):1042- 1050.
  • 9Franceschi S,Herrero R,Clifford GM,et al. Variations in the age-specific curves of human papillomavirus preva- lence in women worldwide[J], lnt J Cancer,2006,119(1 l): 2677-2684.
  • 10Wu RF,Dai M,Qiao YL,et al. Human papillomavirus in- fection in women in Shenzhen,People's Republic of Chi- na,a population typical of recent Chinese urbanization[J]. Int J Cancer, 2007,121 (6): 1306-1311.

共引文献576

同被引文献72

引证文献8

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部